Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following BL-8040 Update

Go back to Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following BL-8040 Update

Form 6-K BioLineRx Ltd. For: May 04

May 4, 2015 7:02 AM EDT

SECURITIES AND EXCHANGE COMMISSION   WASHINGTON, D.C.... More